Literature DB >> 15085971

The aqueous levels of TGF-beta2 in patients with glaucoma.

Altan Atakan Ozcan1, Nusret Ozdemir, Abdullah Canataroglu.   

Abstract

PURPOSE: To evaluate the aqueous levels of transforming growth factor beta-2 (TGF-beta2) in open angle glaucoma patients.
METHODS: The aqueous levels of active TGF-beta2 were detected in 17 eyes of 17 patients using ELISA method. The control group consisted of 6 cataract extracted patients.
RESULTS: Mean age of the patients (60.8 +/- 8.8 years) was similar to that of the controls (57.5 +/- 9.8 years) (p = 0.516). Levels of TGF-beta2 in aqueous samples of glaucoma patients (2.74+/- 1.23 ng/ml) were found to be elevated when compared to those of controls (1.67 +/- 0.32 ng/ml) (p = 0.020).
CONCLUSION: We might suggest that the elevated levels of TGF-beta2 in the aqueous of glaucoma patients could play a role in the pathogenesis of glaucoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15085971     DOI: 10.1023/b:inte.0000018524.48581.79

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  11 in total

Review 1.  The extracellular matrix and its modulation in the trabecular meshwork.

Authors:  B Y Yue
Journal:  Surv Ophthalmol       Date:  1996 Mar-Apr       Impact factor: 6.048

2.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

Authors:  R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

3.  Transforming growth factor-beta 1, -beta 2 and -beta 3 mRNA expression in human cornea.

Authors:  K Nishida; C Sotozono; W Adachi; S Yamamoto; N Yokoi; S Kinoshita
Journal:  Curr Eye Res       Date:  1995-03       Impact factor: 2.424

4.  Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes.

Authors:  M Inatani; H Tanihara; H Katsuta; M Honjo; N Kido; Y Honda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-02       Impact factor: 3.117

5.  Transforming growth factor-beta in human aqueous humor.

Authors:  H D Jampel; N Roche; W J Stark; A B Roberts
Journal:  Curr Eye Res       Date:  1990-10       Impact factor: 2.424

6.  Transforming growth factor-beta 1 and -beta 2 positively regulate TGF-beta 1 mRNA expression in trabecular cells.

Authors:  J Li; B J Tripathi; K V Chalam; R C Tripathi
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-12       Impact factor: 4.799

7.  Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study.

Authors:  Dilani Siriwardena; Peng T Khaw; Anthony J King; Mark L Donaldson; Barry M Overton; Clive Migdal; M Francesca Cordeiro
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

8.  Trabecular cells of the eye express messenger RNA for transforming growth factor-beta 1 and secrete this cytokine.

Authors:  R C Tripathi; J Li; N S Borisuth; B J Tripathi
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-07       Impact factor: 4.799

9.  Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2.

Authors:  R C Tripathi; J Li; W F Chan; B J Tripathi
Journal:  Exp Eye Res       Date:  1994-12       Impact factor: 3.467

10.  Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye.

Authors:  L R Pasquale; M E Dorman-Pease; G A Lutty; H A Quigley; H D Jampel
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-01       Impact factor: 4.799

View more
  59 in total

1.  Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells.

Authors:  Coralia Luna; Guorong Li; Jianming Qiu; David L Epstein; Pedro Gonzalez
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

2.  Evidence-based pathophysiology of glaucoma.

Authors:  Cristina Alexandrescu; Ana-Maria Dascalu; Costin Mitulescu; Aida Panca; Ruxandra Pascu; Radu Ciuluvica; V Potop; Liliana Mary Voinea
Journal:  Maedica (Buchar)       Date:  2010-07

3.  Comparison of lens oxidative damage induced by vitrectomy and/or hyperoxia in rabbits.

Authors:  Hong Yan; Dan Wang; Tian-Bing Ding; Hai-Yan Zhou; Wei-Jia Yan; Xin-Chuan Wang
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

4.  Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients.

Authors:  John Kuchtey; Jessica Kunkel; L Goodwin Burgess; Megan B Parks; Milam A Brantley; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-24       Impact factor: 4.799

5.  Effect of hevin deletion in mice and characterization in trabecular meshwork.

Authors:  Min Hyung Kang; Dong-Jin Oh; Douglas J Rhee
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-06       Impact factor: 4.799

6.  Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.

Authors:  Tara Tovar-Vidales; Abbot F Clark; Robert J Wordinger
Journal:  Exp Eye Res       Date:  2011-06-24       Impact factor: 3.467

Review 7.  The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.

Authors:  John Kuchtey; Rachel W Kuchtey
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-12       Impact factor: 2.671

8.  Gremlin Induces Ocular Hypertension in Mice Through Smad3-Dependent Signaling.

Authors:  Colleen M McDowell; Humberto Hernandez; Weiming Mao; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

Review 9.  The many faces of the trabecular meshwork cell.

Authors:  W Daniel Stamer; Abbot F Clark
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

10.  Aqueous humor level of sCD44 in patients with degenerative myopia and primary open-angle glaucoma.

Authors:  Yasemin U Budak; Muberra Akdogan; Kagan Huysal
Journal:  BMC Res Notes       Date:  2009-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.